Correlation Between Lipocine and Nano Mobile

Can any of the company-specific risk be diversified away by investing in both Lipocine and Nano Mobile at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Nano Mobile into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipocine and Nano Mobile Healthcare, you can compare the effects of market volatilities on Lipocine and Nano Mobile and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Nano Mobile. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Nano Mobile.

Diversification Opportunities for Lipocine and Nano Mobile

0.27

Correlation Coefficient

Lipocine  Nano Mobile

Modest diversification

The 3 months correlation between Lipocine and Nano is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Nano Mobile Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nano Mobile Healthcare and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Nano Mobile. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nano Mobile Healthcare has no effect on the direction of Lipocine i.e., Lipocine and Nano Mobile go up and down completely randomly.

Pair Corralation between Lipocine and Nano Mobile

Given the investment horizon of 90 days Lipocine is expected to under-perform the Nano Mobile. But the stock apears to be less risky and, when comparing its historical volatility, Lipocine is 5.69 times less risky than Nano Mobile. The stock trades about -0.1 of its potential returns per unit of risk. The Nano Mobile Healthcare is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Nano Mobile Healthcare on December 19, 2024 and sell it today you would earn a total of  0.00  from holding Nano Mobile Healthcare or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lipocine  vs.  Nano Mobile Healthcare

Lipocine

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Nano Mobile Healthcare

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nano Mobile Healthcare are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Nano Mobile demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lipocine and Nano Mobile

The main advantage of trading using opposite Lipocine and Nano Mobile positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Nano Mobile can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nano Mobile will offset losses from the drop in Nano Mobile's long position.

The idea behind Lipocine and Nano Mobile Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.